FIELD: biotechnology, genetic engineering, immunology.
SUBSTANCE: invention proposes: isolated nucleic acid encoding feline ligand CD86; diagnostic oligonucleotide; cloning vector; vaccine for modulation of the immune response in cat; method for induction, enhancement and suppression of immune response in cats. Proposed group of inventions allows designing effective vaccines used in prophylaxis of immunodeficiency in felines and infectious peritonitis in domestic cats. Invention can be used in veterinary science.
EFFECT: valuable properties of nucleic acid.
27 cl, 13 dwg, 5 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NUCLEIC ACIDS, CODING RECEPTOR CTLA-4 OF CAT, VECTORS, HOST CELLS, VACCINES, OLIGONUCLEOTIDES, POLYPEPTIDES CTLA-4 OF CAT AND METHODS FOR INDUCTION AND SUPPRESSION OF IMMUNE RESPONSE IN CAT | 1999 |
|
RU2377302C2 |
| RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CTLA-4 OR FELINE CD86 AND ITS APPLYING | 1999 |
|
RU2244006C2 |
| SOLUBLE MUTANT CTLA4 MOLECULES | 1998 |
|
RU2235555C2 |
| IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS | 2008 |
|
RU2506275C2 |
| CTLA-4 VARIANTS | 2013 |
|
RU2671465C2 |
| PEPTIDE THAT SPECIFICALLY INTERACTS WITH THE HUMAN IMMUNE RESPONSE CONTROL MOLECULE B7-2 (CD86) | 2022 |
|
RU2808419C1 |
| COMPOSITIONS AND METHODS OF IMMUNOTHERAPY | 2014 |
|
RU2680010C2 |
| M2-DEFECTIVE POXVIRUS | 2019 |
|
RU2819245C2 |
| HUMANIZED MONOCLONAL ANTIBODY RAISED AGAINST AILIM, CO-STIMULATING MOLECULE FOR SIGNAL TRANSFER AND ITS PHARMACEUTICAL APPLYING | 2001 |
|
RU2262511C2 |
| SILENT ANTI-CD28-ANTIBODY AND THEIR APPLYING | 2001 |
|
RU2261723C2 |
